TUESDAY, Feb. 9, 2021 (HealthDay News) — A new drug combination for advanced liver cancer can extend people’s lives substantially more than the long-standing drug of choice, new study findings confirm. The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV)Continue Reading

MONDAY, Feb. 8, 2021 (HealthDay News) — While scientists still don’t know what causes Parkinson’s disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness. A team led by scientists at the University ofContinue Reading

MONDAY, Feb. 8, 2021 (HealthDay News) — Livestock workers have an elevated risk of getting infected with dangerous, antibiotic-resistant “superbug” bacteria, a new study shows. Researchers from Michigan State University expected that finding when studying those risks by reviewing 15 years of published literature. They just didn’t expect the risksContinue Reading

SUNDAY, Feb. 7, 2021 (HealthDay News) — Doctors need to do a better job of discussing low blood sugar with patients who take high-risk diabetes medications such as insulin, researchers say. Low blood sugar (hypoglycemia) is the most common serious side effect of diabetes treatment. Severe cases can lead toContinue Reading